The genomic revolution: what does it mean for risk assessment?
Risk Anal
.
2001 Dec;21(6):983-7.
doi: 10.1111/0272-4332.216167.
Authors
W E Bishop
1
,
D P Clarke
,
C C Travis
Affiliation
1
Global Technical Policy Department, The Procter and Gamble Company, Cincinnati, OH 45201, USA.
PMID:
11824687
DOI:
10.1111/0272-4332.216167
No abstract available
MeSH terms
Animals
Ecology
Genomics*
Humans
Risk Assessment*
Toxicology